InvisiShield Technologies

Biologics & Biosimilars · Health Care
$3.4Mtotal raised · 2 rounds on record
$2.5Mlatest round · Venture round · Sep 2022 · 4 yr ago
10+team · employees, estimated range
2021founded

Overview

At InvisiShield Technologies, we believe in preventing respiratory infections before they strike. Our mission is to create innovative solutions to protect people from airborne illnesses caused by respiratory viruses, starting with COVID-19, flu and RSV.

Funding and backers

Total raised
$3.4M
2 rounds on record
Latest round
$2.5M
Venture round · Sep 2022 · 4 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
49 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 26, 2022 Raised a round Venture round $2.5M · SEC Form D Jan 27, 2022 Raised a round Venture round $900k · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2022 $2.5M — SEC Form D
Venture round Jan 2022 $900k — SEC Form D
Founders and leadersfrom filings, registers and the company's site
Cheng LiuExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
GV
backs Leyden Labs
High-Tech Gründerfonds
backs Alentis Therapeutics
SOSV
backs Puna Bio
RA Capital Management
backs Alentis Therapeutics
F-Prime Capital
backs Leyden Labs
OrbiMed
backs Alentis Therapeutics
Similar startupsby what they do, their industry and backers
Nuance Pharma501-1000 employees
Nuance Pharma are an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset…
Leyden LabsVenture round $43.2M · 4 mo ago · Founded 2020 · 2 roles
Leyden Labs helps people live freely by developing products that protect from known and new respiratory viruses.
Trellis BioscienceSeries C $9.1M · 9 mo ago
Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.
Serca PharmaceuticalsFounded 2018 · 201-500 employees
Our mission is to improve the quality of life of patients with myocardial infarction (MI) and heart failure by providing novel…
Puna BioVenture round $20.3M · 20 mo ago · Founded 2020 · 51-200 employees
Puna Bio develops crop biologicals from extremophile microorganisms. Its strains come from high-altitude Argentine environments with harsh…
Tolerance BioVenture round $15.1M · 5 mo ago · Founded 2023 · 51-200 employees
Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance.

Financials

Total raised
$3.4M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $2.5M Details
Venture - Series Unknown 2022 $900k Details

People

Cheng Liu
Executive Officer, Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Emeryville United States
HQ
Benjamin Franklin
10-50 est. staff
5858 Horton St, Suite 370, Emeryville, CA 94608
company site